Feed/Investors/3W Partners Capital

3W Partners Capital

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2022-03-23

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$175M

across 1 round

LATEST ROUND

Series C · $175M · 2022-03-23

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
LifeMine LifeMine is a clinical-stage biopharmaceutical company that develops next-generation precision medicines through an innovative drug discovery approach focused on evolutionary insights from fungi, targeting patients in need of breakthrough therapies.	Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$175M	2022-03-23	[ PART ]